Announcing SHOP.COM Groceries$5.99 Flat rate Shipping! Shop now

Heart Health™ System

Heart Health™ System

Price  $104.95
Cashback$2.10
Cashback
The Heart Health System is comprised of Heart Health Essential Omega III Fish Oil with Vitamin E, Heart Health TriActive™, and Heart Health Advanced LipiTrim® Ultra, all designed to promote overall cardiovascular health. Heart Health Essentia...
Includes Advanced LipiTrim Ultra; Essential Omega III Fish Oil; TriActive (30-Day Supply)
Enter Quantity  
Ship Free
Calculate Shipping
by zip code
or by
state or country

One-time delivery
Save 5% by adding to AutoShip and never run out again!
  • Select an AutoShip eligible item, and toggle the "Add to AutoShip" option on the right.
  • Add as many of your favorite items as you like. Create as many AutoShips (with different delivery dates) as you need.
  • Receive a 5% discount on your AutoShip order of Market America products every time!
Something...
Add to Trend
Set Price Alert
Add to eGift
Add to Gift Registry
Save for later
|||
Store Info
 
Product Info
Heart Health™ System

The Heart Health System is comprised of Heart Health Essential Omega III Fish Oil with Vitamin E, Heart Health TriActive™, and Heart Health Advanced LipiTrim® Ultra, all designed to promote overall cardiovascular health. Heart Health Essential Omega III Fish Oil with Vitamin E provides the three grams of EPA† (eicosapentaenoic acid) and DHA† (docosahexaenoic acid) that studies reveal is the most effective amount to promote overall cardiovascular health. Heart Health Advanced LipiTrim Ultra is composed of Sytrinol®, a patented proprietary formula derived from natural citrus polymethoxylated flavones (PMFs) and palm tocotrienols, designed to promote overall cardiovascular health. Sytrinol works in the liver without inhibiting the production of CoQ10. Advanced LipiTrim Ultra is a powerful antioxidant; it helps promote delivery of healthy levels of LDL throughout the body, promotes a normal rate of cholesterol production, promotes healthy levels of total cholesterol, LDL cholesterol and triglyceride levels, and promotes the normal synthesis of triglycerides in the liver. Heart Health TriActive targets three major areas, the arteries, cholesterol and homocysteine levels to promote the healthy performance of the body’s cardiovascular system. This unique formula uses a combination of natural ingredients that have been shown to safely and effectively support optimal arterial function and help maintain normal cholesterol and homocysteine levels.*
 

†According to the FDA, supportive, but not conclusive, research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease.


Compare
Benefits
Ingredients
News
Science
FAQ

Heart Health Advanced LipiTrim Ultra

  • Ameer B, Weintraub RA, Johnson JV, Yost RA, Rouseff RL. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin Pharmacol Ther. 1996 Jul; 60(1): 34-40.
  • Bok SH, Lee SH, Park YB, Bae KH, Son KH, Jeong TS, Choi MS Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr. 1999 Jun;129(6):1182-5.
  • Borradaile NM, de Dreu LE, Barrett PH, Behrsin CD, Huff MW. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation. Biochemistry. 2003 Feb 11; 42(5) - 1283-91.
  • Borradaile NM, de Dreu LE, Barrett PH, Huff MW. Inhibition of hepatocyte apoB secretion by naringenin - enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters. J Lipid Res. 2002 Sep;43(9):1544-54.
  • Borradaile, N.M., Carroll, K.K., and Kurowska, E.M., Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavones hesperitin and naringenin, Lipids, 34: 491-598, 1999
  • Borradaile, N.M., Carroll, K.K. and Kurowska, E.M. Regulation of apo B metabolism in HepG2 cells by the citrus flavanones hesperetin and naringenin. Lipids 34 (1999) 591-598.
  • Bors, W., Heller, W., Michel, C., and Saran, M., Flavonoids as antioxidants: determination of radical scavenging efficiencies, Method Enzymol., 186:343-355, 1990.
  • Cheeke, P.R., Nutrition and nutritional disease, in The Biology of the Laboratory Rabbit, Manning, P.J., Ringler, D.H., and Newcomer, C.E., Eds., Academic Press, San Diego, CA, 1994.
  • Chiba H, Uehara M, Wu J, Wang X, Masuyama R, Suzuki K, Kanazawa K, Ishimi Y. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr. 2003 Jun; 133(6): 1892-7.
  • Choi, J.S., Yokozawa, T., and Oura, H., Antihyperlipidemic effect of flavonoids from Prunus davidiana, J. Nat. Prod., 54:218-224, 1991.
  • Cook, N.C. and Samman, S., Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources, J. Nutr. Biochem., 7:66-76, 1996.
  • Dixon JL, Ginsberg HN Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J Lipid Res. 1993 Feb; 34(2):167-79. Review
  • Erlund I, Silaste ML, Alfthan G, Rantala M, Kesaniemi YA, Aro A. Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr. 2002 Sep; 56(9): 891-8.
  • Hansen, M.B., Nielsen, S.E., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Meth., 119:203-210, 1989.
  • Hayes, K.C., Pronczuk, A. and Liang, J.S. Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols: Observations in humans and hamsters. P. Soc. Exp. Biol. Med. 202 (1993) 353-359.
  • Horowitz, R.M, Gentili, B. Flavonoid constituents of Citrus. In Citrus Science and Technology; Nagy, S., Shaw, P.E., Veldhuis, M.K., Eds.; Avi Publishing Company, Inc.; Westport, CT, 1977; Vol 1, pp 397-426
  • Kamat JP, Sarma HD, Devasagayam TP, Naseratnam K and Basiron Y. Tocotrienols from palm oil as effective inhibitors of protein oxidation and lipid peroxidation in rat liver microsomes. Mol. Cell Biochem. 170:131-137, 1997.
  • Kawaguchi, K., Mizuno, T., Aida, K., and Uchino, K. Hesperidin as an inhibitor of lipases from porcine pancreas and pseudomonas. Biosci. Biotech. Biochem., 61:102-104, 1997.
  • Khor, H.T., Chieng D.Y., and Ong, K.K. Tocotrienols inhibit liver HMG-CoA reductase activity in the guinea pig. Nutr. Res., 15:537:544, 1995.
  • Kurowska EM Determination of cholesterol-lowering potential of minor dietary components by measuring apolipoprotein B responses in HepG2 cells. Methods Enzymol. 2001; 335:398-404.
  • Kurowska EM, Manthey JA, Casaschi A, Theriault AG. Modulation of HepG2 cell net apolipoprotein B secretion by the citrus polymethoxyflavone, tangeretin. Lipids. 2004 Feb; 39(2): 143-51.
  • Kurowska, E.M. and Borradaile, N.M., Hypercholesterolemic effects of dietary citrus juices in rabbits, Nutr. Res., 20: 121-129, 2000.
  • Kurowska, E.M., Hrabek-Smith, J.M., and Carroll, K.K., Compositional changes in serum lipoproteins during developing hypercholesterolemia induced in rabbits by cholesterol-free semipurified diets, Atherosclerosis, 78: 159-165, 1989.
  • Kurowska EM, Manthey JA. Regulation of lipoprotein metabolism in HepG2 cells by citrus flavonoids. Adv Exp Med Biol. 2002; 505:173-9. Review.
  • Kurowska EM, Manthey JA. Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia. J Agric Food Chem. 2004 May 19;52(10):2879-86.
  • Kurowska, E.M., Morley, K. and Gapor, A. Role of tocotrienols from palm oil in regulation of apo B metabolism in HepG2 cells. Experimental Biology 99, Washington, DC, April 17-21, 1999.
  • Kurowska, E.M., Morley, K., and Gapor, A. Regulation of apo B production in HepG2 cells by tocotrienols from palm oil. Proceedings, PORIM International Palm Oil Congress, Kuala Lumpur, Malaysia, 212-219, 1999.
  • Kurowska EM, Spence JD, Jordan J, Wetmore S, Freeman DJ, Piche LA, Serratore P. HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr. 2000 Nov;72(5):1095-100.
  • Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Remesy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr. 2003 Feb;57(2):235-42.
  • Manthey JA, Grohmann K, Guthrie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem. 2001 Feb;8(2):135-53. Review.
  • Mensink, R.P., van Houwelingen, A.C., Kromhout, D., and Hornstra, G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am. J. Clin. Nutr., 69:213-219, 1999.
  • Monforte, M.T., Trovato, A., Kirjavainen, S., Forestieri, A.M., and Galati, E.M. Biological effects of hesperidin, a citrus flavonoid. (note II): hypolipidemic activity on experimental hypercholesterolemia in rat. Farmaco 50:595-599, 1995.
  • Murakami A, Koshimizu K, Ohigashi H, Kuwahara S, Kuki W, Takahashi Y, Hosotani K, Kawahara S, Matsuoka Y. Characteristic rat tissue accumulation of nobiletin, a chemopreventive polymethoxyflavonoid, in comparison with luteolin. Biofactors. 2002; 16(3-4): 73-82.
  • Murakami A, Kuwahara, S., Takahashi Y , Ito, C., Furukawa, H., Ju-Ichi, M. In Vitro absorption and metabolism of nobiletin, a chemopreventive polymethoxyflavonoid in citrus fruits. Biosci., Biotechnol., Biochem. 2001. 65. 194-197.
  • Nielsen SE, Breinholt V, Cornett C, Dragsted LO Biotransformation of the citrus flavone tangeretin in rats. Identification of metabolites with intact flavane nucleus. Food Chem Toxicol. 2000 Sep;38(9):739-46.
  • Nielsen SE, Breinholt V, Justesen U, Cornett C, Dragsted LO. In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica. 1998 Apr;28(4):389-401.
  • Parker, R.A., Pearce, B.C., Clark, R.W., Gordon, D.A., and Wright J.J.K. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem., 268:11230-11238, 1993.
  • Pearce, B.C., Parker, R.A., Deason, M.E., Quereshi, A.A., and Wright J.J.K. Hypercholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem., 35:3595-3606, 1992.
  • Quereshi, A.A., Bradlow, B.A., Brace, L. et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 30 (1995) 1171-1177.
  • Quereshi, A.A., Bradlow, B.A., Salser, W.A., and Brace, L.D. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. J. Nutr. Biochem., 8:290-298, 1997.
  • Quereshi, A.A., Pearce, B.C., Nor, R.M., Gapor, A., Peterson, D.M. and Elson. C.E. Dietary a-tocopherol attenuates the impact of g-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in chickens. J. Nutr., 126:389-394, 1996.
  • Quereshi, A.A., Quereshi, N., Hasler-Rapacz, J.O. et al. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, tromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am. J. Clin. Nutr. 53 (1991) 1042S-1046S.
  • Quereshi, A.A., Quereshi, N., Wright J.J.K., Shen, Z., Kramer, G., Gapor, A., Chong, Y.H., DeWitt, G., Ong, A.S.H., Peterson, D.M., and Bradlow, B.A. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am. J. Clin. Nutr., 53:1021S-1026S, 1991.
  • Quereshi, N. and Quereshi, A.A. Tocotrienols: Novel hypocholesterolemic agents with antioxidant properties. In: Vitamin E in Health and Disease, Packer L. and Fuchs, J. (eds.) Marcel Dekker, Inc., New York 1993, 247-267.
  • Shin, Y.W., Bok, S.H., Jeong, T.S., Bae, K.H., Jeoung, N.H., Choi, M.S., Lee, S.H. and Park, Y.B. Hypocholesterolemic effect of naringin associated with hepatic cholesterol regulating enzyme changes in rats. Int. J. Vitam. Nutr. Res. 69 (1999) 341-347.
  • Spencer JP, Chowrimootoo G, Choudhury R, Debnam ES, Srai SK, Rice-Evans C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett. 1999 Sep 17;458(2):224-30
  • Theriault, A., Chao, J.T., Wang, Q., Gapor, A. and Adeli, K. Tocotrienol: A review of its therapeutic potential. Clin. Biochem 32 (1999) 309-319.
  • Theriault, A., Wang, Q., Gapor, A., and Adeli, K. Effects of g-tocotrienol on apoB synthesis, degradation, and secretion in HepG2 cells. Arterioscler. Tromb. Vac. Biol., 19:714-712, 1999.
  • Theriault, A., Wang, Q., Gapor, A., and Adeli, K. Effects of g-tocotrienol on apoB synthesis, degradation, and secretion in HepG2 cells. Arterioscler. Tromb. Vac. Biol., 19:714-712, 1999.
  • Thrift, R.N., Forte, T.M., Cahoon, B.E., and Shore, V.G., Characterization of lipoprotein produced by the human liver cell line HepG2, under defined conditions, J. Lipid Res., 27: 236-250, 1986.
  • Tomeo AC, Geller M, Watkins TR, Gapor A and Bierenbaum ML. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 30:1179-1183, 1995.
  • Watkins, T., Lenz, P., Gapor, A., Struck, M., Tomeo, A., and Bierenbaum, M. g-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diet. Lipids 28:1113-1118, 1993.
  • Wilcox, L.J., Borradaile, N.M. and Huff, M.W. Antiatherogenic properties of naringenin, a citrus flavonoid. Cardiovasc. Drug Rev. 17 (1999) 160-178.
  • Wilcox LJ, Borradaile NM, de Dreu LE, Huff MW. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res. 2001 May; 42(5): 725-34.
  • Wilcox, L.J., Borradaile, N.M., Kurowska, E.M. Telford, D.E., and Huff, M.W., Naringenin, a citrus flavonoids, markedly decreases apoB secretion in HepG2 cells and inhibits acyl CoA: cholesterol acyltransferase, Circulation, 98: 1-537, 1998.
  • Delaney B, Phillips K, Vasquez C, Wilson A, Cox D, Wang HB, Manthey J.Genetic toxicity of a standardized mixture of citrus polymethoxylated flavones. Food Chem Toxicol. 2002 May;40(5):617-24.
  • Delaney B, Phillips K, Buswell D, Mowry B, Nickels D, Cox D, Wang HB, Manthey J. Immunotoxicity of a standardized citrus polymethoxylated flavone extract. Food Chem Toxicol. 2001 Nov; 39(11): 1087-94.
  • Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M. Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem. 1999 May; 63(5):896-9.
  • Manthey JA, Guthrie N. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem. 2002 Oct 9; 50(21): 5837-43.
  • Manthey JA, Grohmann K. Phenols in citrus peel byproducts. Concentrations of hydroxycinnamates and polymethoxylated flavones in citrus peel molasses. J Agric Food Chem. 2001 Jul; 49(7): 3268-73.
  • Manthey JA, Grohmann K, Montanari A, Ash K, Manthey CL. Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes. J Nat Prod. 1999 Mar; 62(3): 441-4.
  • Mora A, Paya M, Rios JL, Alcaraz MJ. Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. Biochem Pharmacol. 1990 Aug 15; 40(4): 793-7.
  • Takanaga H, Ohnishi A, Yamada S, Matsuo H, Morimoto S, Shoyama Y, Ohtani H, Sawada Y. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. J Pharmacol Exp Ther. 2000 Apr; 293(1):230-6.


Heart Health Essential Omega III Fish Oil with Vitamin E

  • Madsen T, Skou HA, et al, C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease.  Am J Cardiol 88:1139-42 (2001)
  • Rigelsky, JM, et al, Hawthorn: pharmacology and therapeutic uses.  Am J Health Syst Pharm 59:417-22 (2002)
  • Kris-Etherton PM, et al, fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.  Arterioscler Thromb Vasc Biol 23(2):e20-e30 (2003)
  • Morris, MC, Sacks F, Rosner B.  Does fish oil lower blood pressure?  A meta-analysis of controlled trials.  Circulation 88(2):523-533 (19930
  • Howe PR.  Dietary fats and hypertension.  Focus on fish oil.  Ann NY Acad Sci 827:339-352 (1997)
  • Morris MC, et al, The effect of fish oil on blood pressure in mild hypertensive subjects: a randomized crossover trial.  Am J Clin Nutr 57(1):59-64 (1993)
  • Knapp HR, FitzGerald GA.  The antihypertensive effects of fish oil.  A controlled study of polyunsaturated fatty acid supplements in essential hypertension.  J Engl J Med 320(16):1037-1043 (1989)
  • Bonaa, KH, et al, Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension.  A population-based intervention trial from the Tromso study.  N Engl J Med 322(12):795-801 (1990)
  • Chan JK, et al, Dietary alpha-linolenic acid is as effective as oleic acid and linoleic acid in lowering blood cholesterol in normolipidemic men.  Am J Clin Nutr 53(5):1230-1234 (1991)
  • Harris WS, et al, Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia.  Metabolism 33(11):1016-1019 (1984)
  • Nestel PJ.  Fish oil attenuates the cholesterol induced rise in lipoprotein cholesterol.  Am J Clin Nutr 43(5):752-757 (1986)
  • Tsai PJ, Lu SC.  Fish oil lowers plasma lipid concentrations and increases the susceptibility of low density lipoprotein to oxidative modification in healthy men.  J Formos Med Assoc 96(9):718-726 (1997)
  • Garrido A, et al, Ingestion of high doses of fish oil increases the susceptibility of cellular membranes to the induction of oxidative stress.  Lipids 24(9):833-835 (1989)


TriActive

  • Bronstrup A et al. Effects of folic acid and combinations of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy young women. American of Journal Clinical Nutrition  68:1104-10, 1998.
  • Brouwer I et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. American of Journal Clinical Nutrition 69:99-104, 1999.
  • den Heijer Met al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arteriosclerosis Thrombosis and Vascular Biology 18:356-61, 1998.
  • Doshi S et al.  Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering.  Circulation 105(1):22-26, 2002.
  • Friso S et al.  Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk.  American of Journal Clinical Nutrition 79(6):992-998, 2004.
  • Gouni-Berthold I and Berthold H. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. American Heart Journal 143:356–365, 2002.
  • Hatano T et al. Flavan dimers with lipase inhibitory activity from Cassia nomame Phytochemistry 46 (5): 893-900, 1997.
  • Kitanaka S. and Takido M. Demethyltorosaflavones C and D from Cassia nomame. Phytochemistry 31:(8) 2927-2929, 1992.
  • Mas R et al. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clinical Pharmacology and Therapeutics 65: 439-47, 1999.
  • McCaddon A et al. Effect of supplementation with folic-acid on relation between plasma homocysteine, folate, and vitamin B12. Lancet 360:173, 2002.
  • McCarty M et al. Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen. Medical Hypotheses 59(3):268-79, 2002. Review.
  • Moghadasian M. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. American Journal of Medicine 107: 588-94, 1999. Review.
  • Normen L et al. Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. American Journal Clinical Nutrition 71: 908-13, 2000.
  • Rigelsky J et al. Hawthorn: pharmacology and therapeutic uses. American Journal of Health-System Pharmacy 59(5):417-22, 2002. Review.
  • Schwinger R et al.  Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP- independently.  Journal of Cardiovascular Pharmacology 35(5):700-707, 2000.
  • Sinal C and Gonzalez F. Guggulsterone: an old approach to a new problem. Trends in Endocrinology and Metabolism. 13:275-6, 2002.
  • Singh R et al.  Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia.  Cardiovascular Drugs and Therapy 4(8):659-664, 1994.
  • Tilvis R et al.  Serum plant sterols and their relation to cholesterol absorption.  American Journal of Clinical Nutrition  43:92-97, 1986.
  • Title M et al.  Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease.  Journal of the American College of Cardiology 36:758-765, 2000.
  • Urizar N et al. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296(5573):1703-6, 2002.
  • Urizar N et al. Gugulipid: a natural cholesterol-lowering agent. Annual Review in Nutrition 23:303-13, 2003. Review.
  • Van den Berg M et al. Combined vitamin B-6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.  Journal Vascular Surgery 20(6):933-940, 1994.
  • van Oort F et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. American of Journal Clinical Nutrition 77:1318-23, 2003.
  • Wald D et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Archives of Internal Medicine 61:695-700, 2001.
  • Wang X et al.  The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL.  Atherosclerosis  172(2):239-246, 2004.
  • Ward M et al. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM: An International Journal of Medicine 90:519-24, 1997.
  • Woo K et al.  Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation.  American Journal of Medicine  112(7):535-539, 2002.
*These statements have not been evaluated by the Food and Drug Administration. This product(s) is not intended to diagnose, treat, cure or prevent any disease.

REVIEW SNAPSHOT®

by PowerReviews
Heart Health™Heart Health System - Single Box (Advanced LipiTrim® Ultra, Essential Omega III Fish Oil, TriActive)
 
4.8

(based on 14 reviews)

Ratings Distribution

  • 5 Stars

     

    (11)

  • 4 Stars

     

    (3)

  • 3 Stars

     

    (0)

  • 2 Stars

     

    (0)

  • 1 Stars

     

    (0)

100%

of respondents would recommend this to a friend.

Pros

  • No side effects (7)
  • Quick-acting (6)
  • Simple to take (5)
  • Long-lasting (4)
  • Alleviates symptoms (3)

Cons

    Best Uses

    • Long-term use (7)
      • Reviewer Profile:
      • Regular user (6), First time user (3)

    Reviewed by 14 customers

    Sort by

    Displaying reviews 1-5

    Back to top

    Previous | Next »

     
    5.0

    Heart Health System

    By SherryH

    from USA

    SHOP CONSULTANT

    Comments about Heart Health™ Heart Health System - Single Box (Advanced LipiTrim® Ultra, Essential Omega III Fish Oil, TriActive):

    I love this product!! Lowered cholesterol 100 pts over 10 months. No need for other dangerous medications! Would highly recommend this!

     
    5.0

    I would buy this product again.

    By I have beef

    from New York, NY

    Comments about Heart Health™ Heart Health System - Single Box (Advanced LipiTrim® Ultra, Essential Omega III Fish Oil, TriActive):

    Take it once daily.

    (1 of 1 customers found this review helpful)

     
    5.0

    Really amazing products

    By YanS

    from USA

    SHOP CONSULTANT

    Comments about Heart Health™ Heart Health System - Single Box (Advanced LipiTrim® Ultra, Essential Omega III Fish Oil, TriActive):

    For one year my mother-in-law keeps taking one package per day and she just got her annual wellness check report several weeks ago. The cholesterol, triglyceride and blood pressure are in normal levels, and she no longer need to take blood pressure medication.

     
    5.0

    I will use this product everyday!..

    By Raquel

    from Gaithersburg, MD

    About Me First Time User

    Verified Buyer

    Pros

    • No Side Effects
    • Quick-Acting
    • Simple To Take

    Cons

      Best Uses

      • Long-Term Use

      Comments about Heart Health™ Heart Health System - Single Box (Advanced LipiTrim® Ultra, Essential Omega III Fish Oil, TriActive):

      love the product..I'm taking it everyday.

       
      5.0

      Good

      By Nikki

      from Doraville, GA

      About Me First Time User

      Pros

      • Long-Lasting
      • No Side Effects
      • Quick-Acting
      • Simple To Take

      Cons

        Best Uses

        • Long-Term Use

        Comments about Heart Health™ Heart Health System - Single Box (Advanced LipiTrim® Ultra, Essential Omega III Fish Oil, TriActive):

        My dad has heart problem, and he has to use medicine everyday. I bought this product for my dad, he uses it, and he just loves it. He feels stronger and also has better sleep!!!

        Displaying reviews 1-5

        Back to top

        Previous | Next »

         
        Product information and prices are provided by merchants and/or third party sources. At SHOP.COM we do everything we can to ensure the accuracy of the product information or prices displayed, but occasionally, errors occur. Please notify SHOP.COM of any information or pricing inaccuracies so that we may immediately notify the merchants to correct the problem. We apologize for any inconvenience this may cause.

        Thanks for signing up for email deals!

        We'll send the emails to:

        Here at SHOP.COM, we take your privacy very seriously. Please take the time to review our privacy policy.

        Happy shopping!

        Close